Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis

[1]  Ping Yang,et al.  Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients , 2017, Japanese journal of clinical oncology.

[2]  Jiejie Xu,et al.  Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma , 2017, Oncology letters.

[3]  J. Cheville,et al.  Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. , 2017, European urology.

[4]  U. Capitanio,et al.  Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project) , 2017, Scandinavian journal of urology.

[5]  Hong-zhao Li,et al.  Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy , 2017, PloS one.

[6]  Choung-Soo Kim,et al.  Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study , 2017, BioMed research international.

[7]  Z. Xing,et al.  Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients , 2017, Oncotarget.

[8]  N. S. Yee,et al.  The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma , 2017, Oncotarget.

[9]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[10]  Hong-zhao Li,et al.  Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma , 2017, Journal of Cancer Research and Clinical Oncology.

[11]  R. Pulido,et al.  The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases , 2016, PloS one.

[12]  C. Kwak,et al.  Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis , 2016, BioMed research international.

[13]  Le Xu,et al.  High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma , 2016, Tumor Biology.

[14]  J. McKenney,et al.  Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution , 2016, The American journal of surgical pathology.

[15]  K. Taari,et al.  Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy , 2016, Scandinavian journal of urology.

[16]  Y. Zhang,et al.  Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma , 2016, Oncotarget.

[17]  H. Moch,et al.  WHO-ISUP-Graduierungssystem für Nierenkarzinome , 2016, Der Pathologe.

[18]  J. Väyrynen,et al.  Clinical impact and network of determinants of tumour necrosis in colorectal cancer , 2016, British Journal of Cancer.

[19]  Ximing J. Yang,et al.  Update on the Diagnosis and Management of Renal Angiomyolipoma. , 2016, The Journal of urology.

[20]  Yuan-feng Yang,et al.  Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma , 2016, Oncotarget.

[21]  E. Bollito,et al.  Classification of Histologic Patterns of Pseudocapsular Invasion in Organ-Confined Renal Cell Carcinoma. , 2016, Clinical genitourinary cancer.

[22]  H. Moch.  [The WHO/ISUP grading system for renal carcinoma]. , 2016, Der Pathologe.

[23]  T. Guzzo,et al.  Simplification of the Fuhrman grading system for renal cell carcinoma. , 2015, The Canadian journal of urology.

[24]  Fei Dong,et al.  Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome. , 2015, Human pathology.

[25]  Chin-Lee Wu,et al.  Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma , 2015, BioMed research international.

[26]  W. Chou,et al.  Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer , 2015, Medicine.

[27]  M. Fiorentino,et al.  The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma. , 2015, Clinical genitourinary cancer.

[28]  Le Xu,et al.  p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma , 2015, International journal of urology : official journal of the Japanese Urological Association.

[29]  A. Horiguchi,et al.  Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma , 2014, Oncology letters.

[30]  J. Park,et al.  Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy. , 2014, Human pathology.

[31]  M. Srougi,et al.  Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma. , 2014, Urologic oncology.

[32]  X. Cui,et al.  Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma , 2014, Chinese medical journal.

[33]  Y. Lotan,et al.  Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival. , 2014, Urologic oncology.

[34]  E. Dundar,et al.  Prognostic Impact of Intratumoral C-Reactive Protein Expression in Patients with Clear Cell Renal Cell Carcinoma , 2013, Urologia Internationalis.

[35]  T. Tsuzuki,et al.  Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma. , 2013, American journal of clinical pathology.

[36]  K. Pummer,et al.  High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients , 2013, British Journal of Cancer.

[37]  F. Fend,et al.  Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma , 2013, International journal of molecular sciences.

[38]  J. Cheville,et al.  Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. , 2012, The Journal of urology.

[39]  C. Chuang,et al.  Prognostic value of TNM stage and tumor necrosis for renal cell carcinoma , 2011, The Kaohsiung journal of medical sciences.

[40]  F. Montorsi,et al.  Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. , 2011, European urology.

[41]  R. Rocha,et al.  CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma , 2011, World Journal of Urology.

[42]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[43]  J. Cheville,et al.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. , 2010, The Journal of urology.

[44]  T. Skolarus,et al.  Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. , 2010, The Journal of urology.

[45]  P. Rehak,et al.  External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. , 2010, European urology.

[46]  J. Rao,et al.  Re: Presence of Tumor Necrosis is Not a Significant Predictor of Survival in Clear Cell Renal Cell Carcinoma: Higher Prognostic Accuracy of Extent Based Rather Than Presence/Absence Classification , 2009 .

[47]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[48]  F. Roos,et al.  Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma , 2009, BJU international.

[49]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[50]  A. Belldegrun,et al.  Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. , 2009, The Journal of urology.

[51]  Sam S. Chang,et al.  Prognostic factors in T3b renal cell carcinoma , 2009, World Journal of Urology.

[52]  D. McMillan,et al.  Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse‐free and cancer‐specific survival in patients undergoing potentially curative resection for renal cancer , 2008, BJU international.

[53]  F. Kendel,et al.  Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma , 2008, Scandinavian journal of urology and nephrology.

[54]  I. H. Chang,et al.  Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. , 2006, The Journal of urology.

[55]  S. Horvath,et al.  Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma , 2005, Cancer.

[56]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.